img

Global Coagulation Factors Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Coagulation Factors Market Research Report 2024

Coagulation factors such as factor V, factor VIII and factor X play a role in blood clotting
According to Mr Accuracy reports new survey, global Coagulation Factors market is projected to reach US$ 18800 million in 2029, increasing from US$ 12770 million in 2022, with the CAGR of 5.8% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Coagulation Factors market research.
The coagulation factors market has experienced substantial growth in recent years. Coagulation factors are essential proteins involved in the blood clotting process, and deficiencies or abnormalities in these factors can lead to bleeding disorders such as hemophilia and von Willebrand disease. The market growth can be attributed to several factors. Firstly, the increasing prevalence of bleeding disorders, driven by factors such as genetic predisposition, aging population, and improved diagnostic capabilities, has fueled the demand for coagulation factor products. Additionally, advancements in recombinant DNA technology and biotechnology have enabled the development of highly purified and more effective coagulation factor concentrates, offering improved treatment options for patients.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Coagulation Factors market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Takeda
Bayer
CSL
Pfizer
Grifols
Biogen
Octapharma
NovoNordisk
Greencross
Kedrion
BPL
Hualan Bio
RAAS
Segment by Type
Plasma-derived
Recombinant

Segment by Application


Pharmacy
Hospital

Consumption by Region


North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Coagulation Factors report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Coagulation Factors Market Overview
1.1 Product Overview and Scope of Coagulation Factors
1.2 Coagulation Factors Segment by Type
1.2.1 Global Coagulation Factors Market Value Comparison by Type (2024-2034)
1.2.2 Plasma-derived
1.2.3 Recombinant
1.3 Coagulation Factors Segment by Application
1.3.1 Global Coagulation Factors Market Value by Application: (2024-2034)
1.3.2 Pharmacy
1.3.3 Hospital
1.4 Global Coagulation Factors Market Size Estimates and Forecasts
1.4.1 Global Coagulation Factors Revenue 2018-2029
1.4.2 Global Coagulation Factors Sales 2018-2029
1.4.3 Global Coagulation Factors Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Coagulation Factors Market Competition by Manufacturers
2.1 Global Coagulation Factors Sales Market Share by Manufacturers (2018-2024)
2.2 Global Coagulation Factors Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Coagulation Factors Average Price by Manufacturers (2018-2024)
2.4 Global Coagulation Factors Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Coagulation Factors, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Coagulation Factors, Product Type & Application
2.7 Coagulation Factors Market Competitive Situation and Trends
2.7.1 Coagulation Factors Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Coagulation Factors Players Market Share by Revenue
2.7.3 Global Coagulation Factors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Coagulation Factors Retrospective Market Scenario by Region
3.1 Global Coagulation Factors Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Coagulation Factors Global Coagulation Factors Sales by Region: 2018-2029
3.2.1 Global Coagulation Factors Sales by Region: 2018-2024
3.2.2 Global Coagulation Factors Sales by Region: 2024-2029
3.3 Global Coagulation Factors Global Coagulation Factors Revenue by Region: 2018-2029
3.3.1 Global Coagulation Factors Revenue by Region: 2018-2024
3.3.2 Global Coagulation Factors Revenue by Region: 2024-2029
3.4 North America Coagulation Factors Market Facts & Figures by Country
3.4.1 North America Coagulation Factors Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Coagulation Factors Sales by Country (2018-2029)
3.4.3 North America Coagulation Factors Revenue by Country (2018-2029)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Coagulation Factors Market Facts & Figures by Country
3.5.1 Europe Coagulation Factors Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Coagulation Factors Sales by Country (2018-2029)
3.5.3 Europe Coagulation Factors Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Coagulation Factors Market Facts & Figures by Country
3.6.1 Asia Pacific Coagulation Factors Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Coagulation Factors Sales by Country (2018-2029)
3.6.3 Asia Pacific Coagulation Factors Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Coagulation Factors Market Facts & Figures by Country
3.7.1 Latin America Coagulation Factors Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Coagulation Factors Sales by Country (2018-2029)
3.7.3 Latin America Coagulation Factors Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Coagulation Factors Market Facts & Figures by Country
3.8.1 Middle East and Africa Coagulation Factors Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Coagulation Factors Sales by Country (2018-2029)
3.8.3 Middle East and Africa Coagulation Factors Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Coagulation Factors Sales by Type (2018-2029)
4.1.1 Global Coagulation Factors Sales by Type (2018-2024)
4.1.2 Global Coagulation Factors Sales by Type (2024-2029)
4.1.3 Global Coagulation Factors Sales Market Share by Type (2018-2029)
4.2 Global Coagulation Factors Revenue by Type (2018-2029)
4.2.1 Global Coagulation Factors Revenue by Type (2018-2024)
4.2.2 Global Coagulation Factors Revenue by Type (2024-2029)
4.2.3 Global Coagulation Factors Revenue Market Share by Type (2018-2029)
4.3 Global Coagulation Factors Price by Type (2018-2029)
5 Segment by Application
5.1 Global Coagulation Factors Sales by Application (2018-2029)
5.1.1 Global Coagulation Factors Sales by Application (2018-2024)
5.1.2 Global Coagulation Factors Sales by Application (2024-2029)
5.1.3 Global Coagulation Factors Sales Market Share by Application (2018-2029)
5.2 Global Coagulation Factors Revenue by Application (2018-2029)
5.2.1 Global Coagulation Factors Revenue by Application (2018-2024)
5.2.2 Global Coagulation Factors Revenue by Application (2024-2029)
5.2.3 Global Coagulation Factors Revenue Market Share by Application (2018-2029)
5.3 Global Coagulation Factors Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Takeda
6.1.1 Takeda Corporation Information
6.1.2 Takeda Description and Business Overview
6.1.3 Takeda Coagulation Factors Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Takeda Coagulation Factors Product Portfolio
6.1.5 Takeda Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Corporation Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Coagulation Factors Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Bayer Coagulation Factors Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 CSL
6.3.1 CSL Corporation Information
6.3.2 CSL Description and Business Overview
6.3.3 CSL Coagulation Factors Sales, Revenue and Gross Margin (2018-2024)
6.3.4 CSL Coagulation Factors Product Portfolio
6.3.5 CSL Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Coagulation Factors Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Pfizer Coagulation Factors Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Grifols
6.5.1 Grifols Corporation Information
6.5.2 Grifols Description and Business Overview
6.5.3 Grifols Coagulation Factors Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Grifols Coagulation Factors Product Portfolio
6.5.5 Grifols Recent Developments/Updates
6.6 Biogen
6.6.1 Biogen Corporation Information
6.6.2 Biogen Description and Business Overview
6.6.3 Biogen Coagulation Factors Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Biogen Coagulation Factors Product Portfolio
6.6.5 Biogen Recent Developments/Updates
6.7 Octapharma
6.6.1 Octapharma Corporation Information
6.6.2 Octapharma Description and Business Overview
6.6.3 Octapharma Coagulation Factors Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Octapharma Coagulation Factors Product Portfolio
6.7.5 Octapharma Recent Developments/Updates
6.8 NovoNordisk
6.8.1 NovoNordisk Corporation Information
6.8.2 NovoNordisk Description and Business Overview
6.8.3 NovoNordisk Coagulation Factors Sales, Revenue and Gross Margin (2018-2024)
6.8.4 NovoNordisk Coagulation Factors Product Portfolio
6.8.5 NovoNordisk Recent Developments/Updates
6.9 Greencross
6.9.1 Greencross Corporation Information
6.9.2 Greencross Description and Business Overview
6.9.3 Greencross Coagulation Factors Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Greencross Coagulation Factors Product Portfolio
6.9.5 Greencross Recent Developments/Updates
6.10 Kedrion
6.10.1 Kedrion Corporation Information
6.10.2 Kedrion Description and Business Overview
6.10.3 Kedrion Coagulation Factors Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Kedrion Coagulation Factors Product Portfolio
6.10.5 Kedrion Recent Developments/Updates
6.11 BPL
6.11.1 BPL Corporation Information
6.11.2 BPL Coagulation Factors Description and Business Overview
6.11.3 BPL Coagulation Factors Sales, Revenue and Gross Margin (2018-2024)
6.11.4 BPL Coagulation Factors Product Portfolio
6.11.5 BPL Recent Developments/Updates
6.12 Hualan Bio
6.12.1 Hualan Bio Corporation Information
6.12.2 Hualan Bio Coagulation Factors Description and Business Overview
6.12.3 Hualan Bio Coagulation Factors Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Hualan Bio Coagulation Factors Product Portfolio
6.12.5 Hualan Bio Recent Developments/Updates
6.13 RAAS
6.13.1 RAAS Corporation Information
6.13.2 RAAS Coagulation Factors Description and Business Overview
6.13.3 RAAS Coagulation Factors Sales, Revenue and Gross Margin (2018-2024)
6.13.4 RAAS Coagulation Factors Product Portfolio
6.13.5 RAAS Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Coagulation Factors Industry Chain Analysis
7.2 Coagulation Factors Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Coagulation Factors Production Mode & Process
7.4 Coagulation Factors Sales and Marketing
7.4.1 Coagulation Factors Sales Channels
7.4.2 Coagulation Factors Distributors
7.5 Coagulation Factors Customers
8 Coagulation Factors Market Dynamics
8.1 Coagulation Factors Industry Trends
8.2 Coagulation Factors Market Drivers
8.3 Coagulation Factors Market Challenges
8.4 Coagulation Factors Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Coagulation Factors Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Coagulation Factors Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Coagulation Factors Market Competitive Situation by Manufacturers in 2022
Table 4. Global Coagulation Factors Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Coagulation Factors Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Coagulation Factors Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Coagulation Factors Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Coagulation Factors Average Price (USD/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Coagulation Factors, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Coagulation Factors, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Coagulation Factors, Product Type & Application
Table 12. Global Key Manufacturers of Coagulation Factors, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Coagulation Factors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Coagulation Factors as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Coagulation Factors Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Coagulation Factors Sales by Region (2018-2024) & (K Units)
Table 18. Global Coagulation Factors Sales Market Share by Region (2018-2024)
Table 19. Global Coagulation Factors Sales by Region (2024-2029) & (K Units)
Table 20. Global Coagulation Factors Sales Market Share by Region (2024-2029)
Table 21. Global Coagulation Factors Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Coagulation Factors Revenue Market Share by Region (2018-2024)
Table 23. Global Coagulation Factors Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Coagulation Factors Revenue Market Share by Region (2024-2029)
Table 25. North America Coagulation Factors Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Coagulation Factors Sales by Country (2018-2024) & (K Units)
Table 27. North America Coagulation Factors Sales by Country (2024-2029) & (K Units)
Table 28. North America Coagulation Factors Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Coagulation Factors Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Coagulation Factors Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Coagulation Factors Sales by Country (2018-2024) & (K Units)
Table 32. Europe Coagulation Factors Sales by Country (2024-2029) & (K Units)
Table 33. Europe Coagulation Factors Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Coagulation Factors Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Coagulation Factors Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Coagulation Factors Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Coagulation Factors Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Coagulation Factors Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Coagulation Factors Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Coagulation Factors Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Coagulation Factors Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Coagulation Factors Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Coagulation Factors Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Coagulation Factors Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Coagulation Factors Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Coagulation Factors Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Coagulation Factors Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Coagulation Factors Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Coagulation Factors Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Coagulation Factors Sales (K Units) by Type (2018-2024)
Table 51. Global Coagulation Factors Sales (K Units) by Type (2024-2029)
Table 52. Global Coagulation Factors Sales Market Share by Type (2018-2024)
Table 53. Global Coagulation Factors Sales Market Share by Type (2024-2029)
Table 54. Global Coagulation Factors Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Coagulation Factors Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Coagulation Factors Revenue Market Share by Type (2018-2024)
Table 57. Global Coagulation Factors Revenue Market Share by Type (2024-2029)
Table 58. Global Coagulation Factors Price (USD/Unit) by Type (2018-2024)
Table 59. Global Coagulation Factors Price (USD/Unit) by Type (2024-2029)
Table 60. Global Coagulation Factors Sales (K Units) by Application (2018-2024)
Table 61. Global Coagulation Factors Sales (K Units) by Application (2024-2029)
Table 62. Global Coagulation Factors Sales Market Share by Application (2018-2024)
Table 63. Global Coagulation Factors Sales Market Share by Application (2024-2029)
Table 64. Global Coagulation Factors Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Coagulation Factors Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Coagulation Factors Revenue Market Share by Application (2018-2024)
Table 67. Global Coagulation Factors Revenue Market Share by Application (2024-2029)
Table 68. Global Coagulation Factors Price (USD/Unit) by Application (2018-2024)
Table 69. Global Coagulation Factors Price (USD/Unit) by Application (2024-2029)
Table 70. Takeda Corporation Information
Table 71. Takeda Description and Business Overview
Table 72. Takeda Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 73. Takeda Coagulation Factors Product
Table 74. Takeda Recent Developments/Updates
Table 75. Bayer Corporation Information
Table 76. Bayer Description and Business Overview
Table 77. Bayer Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 78. Bayer Coagulation Factors Product
Table 79. Bayer Recent Developments/Updates
Table 80. CSL Corporation Information
Table 81. CSL Description and Business Overview
Table 82. CSL Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 83. CSL Coagulation Factors Product
Table 84. CSL Recent Developments/Updates
Table 85. Pfizer Corporation Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 88. Pfizer Coagulation Factors Product
Table 89. Pfizer Recent Developments/Updates
Table 90. Grifols Corporation Information
Table 91. Grifols Description and Business Overview
Table 92. Grifols Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 93. Grifols Coagulation Factors Product
Table 94. Grifols Recent Developments/Updates
Table 95. Biogen Corporation Information
Table 96. Biogen Description and Business Overview
Table 97. Biogen Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 98. Biogen Coagulation Factors Product
Table 99. Biogen Recent Developments/Updates
Table 100. Octapharma Corporation Information
Table 101. Octapharma Description and Business Overview
Table 102. Octapharma Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 103. Octapharma Coagulation Factors Product
Table 104. Octapharma Recent Developments/Updates
Table 105. NovoNordisk Corporation Information
Table 106. NovoNordisk Description and Business Overview
Table 107. NovoNordisk Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 108. NovoNordisk Coagulation Factors Product
Table 109. NovoNordisk Recent Developments/Updates
Table 110. Greencross Corporation Information
Table 111. Greencross Description and Business Overview
Table 112. Greencross Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 113. Greencross Coagulation Factors Product
Table 114. Greencross Recent Developments/Updates
Table 115. Kedrion Corporation Information
Table 116. Kedrion Description and Business Overview
Table 117. Kedrion Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 118. Kedrion Coagulation Factors Product
Table 119. Kedrion Recent Developments/Updates
Table 120. BPL Corporation Information
Table 121. BPL Description and Business Overview
Table 122. BPL Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 123. BPL Coagulation Factors Product
Table 124. BPL Recent Developments/Updates
Table 125. Hualan Bio Corporation Information
Table 126. Hualan Bio Description and Business Overview
Table 127. Hualan Bio Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 128. Hualan Bio Coagulation Factors Product
Table 129. Hualan Bio Recent Developments/Updates
Table 130. RAAS Corporation Information
Table 131. RAAS Description and Business Overview
Table 132. RAAS Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 133. RAAS Coagulation Factors Product
Table 134. RAAS Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Coagulation Factors Distributors List
Table 138. Coagulation Factors Customers List
Table 139. Coagulation Factors Market Trends
Table 140. Coagulation Factors Market Drivers
Table 141. Coagulation Factors Market Challenges
Table 142. Coagulation Factors Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Coagulation Factors
Figure 2. Global Coagulation Factors Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Coagulation Factors Market Share by Type in 2022 & 2029
Figure 4. Plasma-derived Product Picture
Figure 5. Recombinant Product Picture
Figure 6. Global Coagulation Factors Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Coagulation Factors Market Share by Application in 2022 & 2029
Figure 8. Pharmacy
Figure 9. Hospital
Figure 10. Global Coagulation Factors Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Coagulation Factors Market Size (2018-2029) & (US$ Million)
Figure 12. Global Coagulation Factors Sales (2018-2029) & (K Units)
Figure 13. Global Coagulation Factors Average Price (USD/Unit) & (2018-2029)
Figure 14. Coagulation Factors Report Years Considered
Figure 15. Coagulation Factors Sales Share by Manufacturers in 2022
Figure 16. Global Coagulation Factors Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Coagulation Factors Players: Market Share by Revenue in 2022
Figure 18. Coagulation Factors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Coagulation Factors Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Coagulation Factors Sales Market Share by Country (2018-2029)
Figure 21. North America Coagulation Factors Revenue Market Share by Country (2018-2029)
Figure 22. the United States Coagulation Factors Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Coagulation Factors Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Coagulation Factors Sales Market Share by Country (2018-2029)
Figure 25. Europe Coagulation Factors Revenue Market Share by Country (2018-2029)
Figure 26. Germany Coagulation Factors Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Coagulation Factors Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. UK Coagulation Factors Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Coagulation Factors Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Coagulation Factors Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Coagulation Factors Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Coagulation Factors Revenue Market Share by Region (2018-2029)
Figure 33. China Coagulation Factors Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Coagulation Factors Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Coagulation Factors Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Coagulation Factors Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Coagulation Factors Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. China Taiwan Coagulation Factors Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Indonesia Coagulation Factors Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Thailand Coagulation Factors Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Malaysia Coagulation Factors Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America Coagulation Factors Sales Market Share by Country (2018-2029)
Figure 43. Latin America Coagulation Factors Revenue Market Share by Country (2018-2029)
Figure 44. Mexico Coagulation Factors Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil Coagulation Factors Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina Coagulation Factors Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Coagulation Factors Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa Coagulation Factors Revenue Market Share by Country (2018-2029)
Figure 49. Turkey Coagulation Factors Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Coagulation Factors Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE Coagulation Factors Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of Coagulation Factors by Type (2018-2029)
Figure 53. Global Revenue Market Share of Coagulation Factors by Type (2018-2029)
Figure 54. Global Coagulation Factors Price (USD/Unit) by Type (2018-2029)
Figure 55. Global Sales Market Share of Coagulation Factors by Application (2018-2029)
Figure 56. Global Revenue Market Share of Coagulation Factors by Application (2018-2029)
Figure 57. Global Coagulation Factors Price (USD/Unit) by Application (2018-2029)
Figure 58. Coagulation Factors Value Chain
Figure 59. Coagulation Factors Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed